BioIVT standardizing site processes following acquisition string
BioIVT will use its new internal cloud-based Quality Management System to manage clinical trial data at all of its locations, following the acquisition of five companies since 2017.
Archives for October 23, 2018
Collaboration to advance high-throughput screening services
Assay.Works and 2bind are partnering to expand the range of discovery services provided for companies in the pharmaceutical and biotech industry, and academic organizations.
Quotient expands operations with early phase manufacturing site
Quotient Sciences, a drug development services organization, will expand its operations with a new early phase formulation development and clinical trial manufacturing facility.
Law to provide reimbursement for clinical trial costs, laying ‘a path forward for change’
Changes at the state and federal level are paving the way for increased participation in clinical trials by providing patient reimbursement for study-related costs.
Looping blockchain, distributed ledger tech into clinical research
Certara is using Hedera’s next-generation distributed ledger technology to help the pharmaceutical industry and other stakeholders to ‘capitalize on the myriad of seemingly insignificant activities.’
Novartis spends $2.1bn on candidate with blockbuster potential
Novartis will acquire Endocyte for $2.1bn, with the core of the deal centering on the latter’s experimental therapy for prostate cancer.
US FDA approves Pfizer’s PARP inhibitor for metastatic breast cancer
The FDA approved Pfizer’s therapy for metastatic breast cancers, after clinical trials showed strong progression-free survival rates.